Khoury Fouad, Javed Fawad, Romanos Georgios E
Int J Oral Maxillofac Implants. 2018 Sep/Oct;33(5):1136-1139. doi: 10.11607/jomi.6517.
This observational study was based on a series of clinical cases in which failure of sinus augmentations occurred in patients who received prophylactic clindamycin therapy.
Between the years 2006 and 2010, a retrospective observational study was performed. The study consisted of 1,874 patients (723 males and 1,151 females) in whom sinus augmentations were performed prior to placement of dental implants.
In nine (0.48%) patients (four males and five females), infection of the graft material inside the sinus floor occurred, and six patients developed an abscess in the site of surgery, 4 to 6 weeks postoperatively. In three patients, a buccal fistula with pus draining was observed 5 to 8 weeks postoperatively. In all patients, the source of infection was from the grafted material within the sinus. A common manifestation in all nine patients was that they had self-reported penicillin allergy and had been prescribed clindamycin (300 mg every 6 hours for 10 days).
Prophylactic clindamycin therapy following sinus augmentation procedures seems to be a risk factor for infections and loss of grafting material following these surgical techniques.
本观察性研究基于一系列临床病例,这些病例中接受预防性克林霉素治疗的患者窦腔增高术失败。
在2006年至2010年期间进行了一项回顾性观察性研究。该研究包括1874例患者(723例男性和1151例女性),他们在植入牙种植体之前进行了窦腔增高术。
9例(0.48%)患者(4例男性和5例女性)发生了窦底内移植材料感染,6例患者在术后4至6周手术部位出现脓肿。3例患者在术后5至8周观察到有脓性分泌物的颊侧瘘管。所有患者的感染源均来自窦腔内的移植材料。所有9例患者的一个共同表现是他们自述对青霉素过敏,并被开具了克林霉素(每6小时300毫克,共10天)。
窦腔增高术后的预防性克林霉素治疗似乎是这些手术技术后感染和移植材料丢失的一个危险因素。